Updated:
ALIMERA SCIENCES INC
ALIMERA SCIENCES INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001267602, and its reported industry is...
Overview
ALIMERA SCIENCES INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001267602, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-08, it reported annual revenue of USD 80,754,000; net income of USD -20,132,000; total assets of USD 153,524,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- ALIMERA SCIENCES INC
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Alpharetta, GA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001267602
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2023USD | $80.8M | -$20.1M | $153.5M | $12.1M | -$14.3M | |
| FY2022USD | $54.1M | -$18.1M | $42.6M | $5.3M | -$10.0M | |
| FY2021USD | $59.0M | -$4.4M | $58.5M | $16.5M | -$3.2M | |
| FY2020USD | $50.8M | -$5.3M | $50.9M | $11.2M | -$2.2M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research ALIMERA SCIENCES INC in Altss
Track this company’s investors, transactions and relationships in Altss.